Karin Bornfeldt, University of Washington, Seattle, USA, reviews research linking elevated apoC3 with coronary artery disease in people with type 1 diabetes, and the potential of apoC3 silencing in preventing atherosclerosis progression.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
